-
Harvey CHEN
Non-equity Partner / Shanghai
-
Tel +86-21-6061-3559
-
Practices

Compliance & Investigation, Investment/M&A & Corporate Governance, Cybersecurity & Data Protection
Harvey CHEN
Mr. Harvey(Fangqiang) CHEN possesses over ten years of legal practice experience in specialized areas such as corporate investment and M&A, regulatory compliance, internal and external investigations, as well as data and artificial intelligence compliance. His practice primarily covers industry sectors including pharmaceuticals and life sciences, medical devices, healthcare, animal health, food and FMCG, telecommunications and information services, artificial intelligence technology and applications, chemicals, equipment manufacturing, and logistics.
In the fields of life sciences and healthcare, Mr. Chen has assisted numerous domestic and foreign multinational corporations as well as innovative enterprises involved in the R&D, production, distribution, and related supply chains of pharmaceuticals and medical devices. He provides legal and compliance services covering the full lifecycle of human drugs, medical devices, and veterinary drugs. His expertise includes early-stage R&D and clinical trial compliance, licensing transactions (License-in/out), CXO collaborations, pharmaceutical product development and commercialization, Marketing Authorization Holder (MAH) transfers, product registration and regulatory compliance, advertising compliance, MAH liability disputes, disputes regarding adverse drug reactions/medical device adverse events, as well as equity and asset acquisitions, cooperative transactions, and the initiation and response to internal and external compliance investigations for relevant enterprises.
In the fields of internet telecommunications services and AI technology, Mr. Chen represents multiple leading internet enterprises, providing general and specialized legal and compliance services regarding internet healthcare, AI applications in the healthcare sector, healthcare data compliance, advertising and commercial promotion compliance, anti-unfair competition, and pharmaceutical e-commerce compliance.
Mr. Chen also previously served on a long-term secondment as legal counsel at a Global Fortune 500 French pharmaceutical company, where he was primarily responsible for legal affairs related to the MNC's Commercial and Emerging Business Units in China.
-
Bar Admissions/Professional Qualifications
PRC Bar
-
Education
LL.M., Shanghai University of International Business and Economics
-
Professional Experience
Non-equity partner, and associate, Zhong Lun Law Firm, 2016 to present
Associate, Martin Hu & Partners, 2015-2016 -
Languages
Chinese
English